含有接骨木莓成分的饮品、软糖等产品在市场上大量销售，商家宣称这类产品具有提升免疫力、预防过敏、止咳等功效1。然而，调查发现这些产品多为普通食品却非法宣称保健功能，其原料合规性受到广泛质疑。消费者李先生于2026年1月4日为孩子购买澳兰泰接骨木莓酵母β-葡聚糖饮品，孩子于1月9日出现身体发痒、腿上出现红色斑疹症状，医院诊断为严重过敏1。
国家卫健委的审批记录显示，其仅批准了接骨木莓花色苷提取物作为新食品原料，而非接骨木莓本身1。推荐食用量不超过3.2克/天（以总花色苷含量10g/100g计）1。多地卫生健康委员会证实当地无接骨木莓传统食用习惯——福建省卫健委答复接骨木莓在当地没有传统食用习惯，江西省卫健委亦确认无相关资料1。此外，行业标准GB/T 31121—2014为推荐性标准而非强制性标准，不能作为食品原料依据1。
面对这一风险，代工厂企业已开始行动。山东药业公司将接骨木莓粉、接骨木莓浓缩汁列为风险原料，停止生产使用1。山东佰诺生物科技有限公司负责人表示："接骨木莓确实不能用了，现在只有接骨木莓花色苷能用"1。在具体产品方面，安琪纽特接骨木莓饮品每袋（15mL）含154mg接骨木莓浓缩汁，售价228元/罐（15mL×28袋）；益可劲食用菌产品中的接骨木莓果汁粉每袋（2.5g）仅含50毫克，添加比例为2%1。
科普作家云无心因缺乏充分安全性和有效性数据，不推荐18岁以下青少年儿童使用接骨木莓1。北京中医药大学卫生健康法学教授邓勇分析指出，普通饮品宣称协助抗病毒、改善呼吸道症状等涉嫌违反《食品安全法》《广告法》1。
Products containing elderberry ingredients, including beverages and soft gummies, are being widely sold with manufacturers claiming they enhance immunity, prevent allergies, and ease coughs.1 However, an investigation has uncovered significant regulatory and safety concerns surrounding these products.
A consumer named Li purchased an Aulanté elderberry yeast beta-glucan beverage for his child on January 4, 2026.1 The child developed itching and red rashes on his legs by January 9, with hospital diagnosis confirming a severe allergic reaction.1 The investigation revealed that many of these products are marketed as ordinary foods while illegally claiming health benefits, and the regulatory status of elderberry as a food ingredient remains questionable.1 The National Health Commission approved only elderberry anthocyanin extract as a novel food ingredient on November 27, 2025, not elderberry itself.1 The recommended daily intake is no more than 3.2 grams per day, calculated on a total anthocyanin content of 10g per 100g.1
Regional health authorities have confirmed the lack of traditional consumption practices for elderberry.1 Fujian's Health Commission reported that elderberry has no traditional food use history in the province, while Jiangxi's Health Commission stated it lacks relevant documentation on traditional elderberry consumption.1 Additionally, the industry standard GB/T 31121—2014 is recommendatory rather than mandatory and cannot serve as a basis for food ingredient approval.1 A major pharmaceutical company in Shandong has classified elderberry powder and concentrated juice as risk materials and ceased production.1 A representative from Shandong Baino Biotechnology stated: "Elderberry indeed cannot be used anymore; now only elderberry anthocyanins are permitted."1
Specific products examined include Anqier Nutrient's elderberry beverage, containing 154 mg of elderberry concentrate per 15 mL sachet, priced at 228 yuan per box of 28 sachets.1 Science communicator Yun Wuxin cautioned against elderberry use for those under 18, citing insufficient safety and efficacy data.1 Professor Deng Yong of Beijing University of Chinese Medicine noted that ordinary beverages claiming antiviral properties or respiratory symptom improvement may violate the Food Safety Law and Advertising Law.1
评论
还没有评论，欢迎留下第一条。